- Patients both genders over 18 years old
- Patients with PsA diagnosis
- Patients with PsA that suffer from other rheumatologic diseases or non-concomitant
rheumatologic diseases that the investigator considers not to be appropriate for the
- Patients with any medical or physical condition (cognitive damage or difficulties for
understanding) that create difficulties for reading and completing the questionnaires
described in the protocol.
- Patients that in the study period are taking part in another clinical trial.